The state government had formed the three-member committee last year to probe 'Putrajeevak Beej', an ayuvedic product which allegedly promises a male child.
The report has been sent to Uttarakhand Chief Minister Harish Rawat and will be submitted to the Union government after he gives the go ahead, state's Principal Secretary, Health, Om Prakash, said.
"The inquiry report on Putrajeevak medicine is not in favour of Ramdev. The report has been sent to Chief Minister Harish Rawat," Prakash said, while refusing to divulge the details.
The Centre had then directed the Uttarakhand government to launch an inquiry into the matter.
However, Ramdev had rejected the allegations, saying the medicine helps in curing infertility in women and termed as "false and misleading" reports that it promises a male child.
The committee, which was earlier headed by AYUSH Drug Controller PD Chamoli, however, gave a clean chit to Ramdev, saying that the nomenclature of the drug was in accordance with the ancient Ayurvedic books and literature.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
